Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print oes peripheral T-lymphocyte subpopulations correlate with hepatitis B virus load?

oes peripheral T-lymphocyte subpopulations correlate with hepatitis B virus load?

July 29, 2009

Hepatitis B virus (HBV) infection is a dynamic process with variable biochemical, virological and histological profiles at different stages of the infection, depending on host and viral factors. Furthermore, this profile may change at a variable pace over time. The correlation between detection of T-cell response and HBV load in chronic HBV infection remains unknown. In each of the clinical stages of chronic HBV infection, whether the composition of T-cell subpopulations is different and relates to viral load. Thus characterization of T-cell profile is relevant to improved understanding of chronic HBV infection and the design of antiviral therapy.

A research article to be published on July 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team, led by Professor Jing You from the Department of Infectious Diseases of the First Affiliated Hospital of Kunming Medical University of China and the Epidemiology Unit of the Faculty of Medicine of Prince of Songkla University of Thailand, investigated the peripheral T-cell subpopulation profiles and their correlation with viral replication in different clinical stages of chronic HBV infection. The article further indicated that the clinical stages of chronic HBV infection, separated on virological and biochemical parameters, have characteristic peripheral T-cell subpopulation profiles. HBV load, in patients at immune-tolerant and -active stages, contributes to the variations of peripheral T cell subpopulation profiles.




The results revealed T-cell impairment was significantly associated with HBV replication level. The substantial linear dose-response relationship and strong independent predictive effect of serum HBV load level on T-lymphocyte subpopulations suggests the possibility of a causal relationship between them. And this relationship exists in immune-tolerant patients and immune-active patients. The multivariate multiple regression analysis demonstrated a partial independent effects of HBeAg and HBV precore mutant infection on T-cell profile. Multivariate multiple regression displayed that log copies of HBV DNA still maintained its highly significant predictive coefficient for T-cell subpopulations, and was the strongest predictor of variation of CD3+, CD4+ and CD8+ cells and CD4+/CD8+ ratio after adjustment for age at HBV-infection, maternal HBV-infection status, presence of HBeAg and HBV mutation, HBV viral load in patients at the immune-tolerant and immune-active stages contributes to the variations in peripheral T cell subpopulation profile, which is relevant to the design of individualized new anti-viral strategies. Further study is required to better understand the complex host-virus interaction that determines the persistence and outcome of HBV infection.

World Journal of Gastroenterology



Related Hepatitis Current Events and Hepatitis News Articles Hepatitis Current Events and Hepatitis News RSS Hepatitis Current Events and Hepatitis News RSS
Toward explaining why hepatitis B hits men harder than women
Scientists in China are reporting discovery of unusual liver proteins, found only in males, that may help explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates -- hitting men harder than women.

Largest-ever database for liver proteins may lead to treatments for hepatitis
Scientists at a group of 11 research centers in China are reporting for the first time assembly of the largest-ever collection of data about the proteins produced by genes in a single human organ.

Mount Sinai finds those with more difficult to treat forms of HCV are half as likely to get treated
A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat.

Extending treatment after liver transplant may benefit patients with hepatitis C recurrence
Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.

Hepatitis B does not increase risk for pancreatic cancer
A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor.

Governor recognizes stem cell research at Einstein
Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today.

Liver cells grown from patients' skin cells
Scientists at The Medical College of Wisconsin in Milwaukee have successfully produced liver cells from patients' skin cells opening the possibility of treating a wide range of diseases that affect liver function.

Injury and hazards in home health care nursing are a growing concern
Patients continue to enter home healthcare ''sicker and quicker," often with complex health problems that may require extensive nursing care.

Medication effective for acute liver failure in early stages of disease
The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found.

New aging studies improving vaccine efficacy for the elderly
A new study from the Trudeau Institute in Saranac Lake, New York, demonstrates that immune system cells important for both pathogen resistance and vaccine efficacy live longer in older animals but because of this longevity acquire functional defects.
More Hepatitis Current Events and Hepatitis News Articles
Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease

Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease
by Melissa Palmer (Author)

In the United States alone, more than four million people are infected with the hepatitis C virus, and chronic liver disease is the twelfth leading cause of death.

In this revised and updated edition of her groundbreaking 2000 book, renowned hepatologist Dr. Melissa Palmer discusses all facets of liver disease, from symptoms and tests to treatment options and lifestyle changes. In addition, this comprehensive handbook reveals cutting-edge research on the dangers of hepatitis C, one of the world's fasting-growing microbial threats.

Living With Hepatitis C For Dummies

Living With Hepatitis C For Dummies
by Nina L. Paul (Author), Gina Pollichino (Foreword)

A comprehensive, empathetic guide for anyone suffering from this serious liver disease

Approximately 4 million Americans and 170 million people worldwide suffer from hepatitis C, a viral liver disease that is treatable but not curable. It accounts for more than 40 percent of U.S. liver disease deaths–about 8,000 to 10,000 people annually–and is the most common reason for liver transplantation. This compassionate guide explains how hepatitis C affects the liver and the body and provides solid advice on today’s treatment options–from drugs (and their side effects) to transplants and alternative therapies–as well as tips on dealing with the emotional and financial burdens the disease brings with it.

Nina L Paul, PhD (New York, NY) earned her doctorate in infectious...

HEPATITIS GIANT MICROBE

HEPATITIS GIANT MICROBE
by Giant Microbes

HAV is spread primarily by unsanitary food and water ? HBV is transmitted in bodily fluids and can cause chronic liver disease ? HCV is perhaps the most dangerous: no vaccine is available

? HDV occurs only in the presence of HBV ? HEV is relatively mild
and non-chronic ? HFV and HGV are newly identified; their connection with liver disease is debated

Understanding Hepatitis C

Understanding Hepatitis C

Part of the award winning public television series Healthy Body/Healthy Mind. Hepatitis C is a blood born disease affecting over 5 million Americans. Dangerously, most people infected aren't even aware they've contracted it. On this program, Infectious Disease Specialists discuss the latest scientific & clinical data including treatment options and their side effects. We visit with real people who for years were unaware they were carrying the virus, found out, sought proper treatment and now live virus free.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

The Hepatitis C Help Book, Revised Edition: A Groundbreaking Treatment Program Combining Western and Eastern Medicine for Maximum Wellness and Healing

The Hepatitis C Help Book, Revised Edition: A Groundbreaking Treatment Program Combining Western and Eastern Medicine for Maximum Wellness and Healing
by Misha Ruth Cohen O.M.D. L. Ac. (Author), Robert Gish (Author), Kalia Doner (Author)

A fully updated and revised edition of an important health guide, including the latest information on optimum interferon protocol. Hepatitis C has been called "the emergent and preeminent public-health problem of the twenty-first century--surpassing HIV." It has also been dubbed "The Shadow Epidemic," because it is one of the most clandestine of viruses and infects healthy people who have no idea they are being attacked by something they can't even detect. Now, the two experts on Hepatitis C who teamed up to write the first comprehensive guide to orthodox and alternative treatment options have revised and fully updated the book to include recent findings in the field. Along with programs for self-care, nutritional and fitness plans and a comprehensive Western and Chinese medical...

Home Access Hepatitis C Check 1 ea

Home Access Hepatitis C Check 1 ea
by Home Access

At-Home Telemedicine Test Service for Hepatitis C*.
Confidentia

  Aids & Hepatitis Digest
by Ccm International Ltd


Provides information to Air Force comptroller personell relating to mission accomplishment, to assist them in solving problems and improving efficiency of operation and to communicate new developments and techniques


Balanceuticals Blood Circulator Dietary Supplement Capsules, 500 mg, 60-Count Bottle

Balanceuticals Blood Circulator Dietary Supplement Capsules, 500 mg, 60-Count Bottle
by Balanceuticals

Dietary Supplement. 100% Natural. Made under Supervision by China Academy of Traditional Chinese Medicine. Made of medicinal rhubarb, prepared rehmannia root, common peony root, peach seed, bitter apricot seed, licorice root, scute, dun fly, gadfly, leech, June beetle, this time-honored formula is used in Chinese medicine to promote micro-circulation, increase blood flow to heart muscles, open and clear arteries, inhibit intestinal adhesion, soothe the liver, remove stasis and maintain healthy blood circulation and regular menses. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

Living with Hepatitis C, Fifth Edition: A Survivor's Guide

Living with Hepatitis C, Fifth Edition: A Survivor's Guide
by Gregory T. Everson (Author)

The Most Trusted Resource and Reference for Millions of Americans

Living with Hepatitis C was the first book to explain in everyday language the causes of this disease, its major and minor symptoms, and all of the latest treatments available. Researchers have continued to make dramatic strides in helping the millions of Americans who suffer from Hepatitis C since the book's first publication, and each new edition has kept up with the most recent findings.

The latest revised Living With Hepatitis C, Fifth Edition includes cutting-edge information on:

* New treatments including pegylated and consensus interferons
* Living-donor transplants
* Co-infections with Hepatitis B and HIV/AIDS
* Promising new clinical trials of protease and polymerase inhibitors
*...

Understanding Hepatitis Anatomical Chart Laminated (In Stock)-9992PL1.5

Understanding Hepatitis Anatomical Chart Laminated (In Stock)-9992PL1.5
by Anatomical Chart Company

Defines viral hepatitis and the types of hepatic viruses that cause this disease: Hepatitis A, B, C, D, E, and recently discovered viruses G and TTV (Transfusion Transmitted Virus). Talks about modes of tranmission and illustrated the complications of hepatitis. Illustrates the anatomy of the liver, pancreas and surrounding structures, including veins and arteries. Shows 3 liver biopsies: normal, mild hepatitis and moderate. Lists the signs and symptoms which progress by stages.

© 2009 BrightSurf.com